JPH09110692A - Bis quaternary ammonium salt compound having antimicrobial activity and its production - Google Patents

Bis quaternary ammonium salt compound having antimicrobial activity and its production

Info

Publication number
JPH09110692A
JPH09110692A JP29500195A JP29500195A JPH09110692A JP H09110692 A JPH09110692 A JP H09110692A JP 29500195 A JP29500195 A JP 29500195A JP 29500195 A JP29500195 A JP 29500195A JP H09110692 A JPH09110692 A JP H09110692A
Authority
JP
Japan
Prior art keywords
compound
formula
ammonium salt
quaternary ammonium
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP29500195A
Other languages
Japanese (ja)
Inventor
Hiroki Koma
寛紀 高麗
Hiroki Manabe
裕希 真鍋
Koji Tsuchitani
浩司 槌谷
Tetsuto Nanba
哲人 難波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inui Corp
Original Assignee
Inui Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inui Corp filed Critical Inui Corp
Priority to JP29500195A priority Critical patent/JPH09110692A/en
Publication of JPH09110692A publication Critical patent/JPH09110692A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a new compound represented by a specific formula, expressing an extremely excellent antimicrobial effect and an extremely wide antimicrobial spectrum, high in safety, and useful as an antimicrobial agent. SOLUTION: This compound is expressed by formula I (Z is a pyridine ring; R1 , R2 are each H, a 1-6C alkyl; R3 is a 3-18C alkylene, a 3-18C alkenylene; R4 is a 6-18C alkyl bound to the ring nitrogen atom of Z; X is an anion), e.g. N,N'-hexamethylene bis(4-carbamoyl-1-dodecylpyridinium bromide). The compound is preferably obtained by reacting an alkylene biscarbamoylpyridine compound of formula II with a compound of the formula: R4 X in an organic solvent such as N,N-dimethylformamide in approximately 10-100MPa at approximately 50-100 deg.C for 10-12hr, etc.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は抗菌活性を有するビス第
四アンモニウム塩化合物及びその製造方法に関する。
TECHNICAL FIELD The present invention relates to a bis-quaternary ammonium salt compound having antibacterial activity and a method for producing the same.

【0002】[0002]

【従来の技術】細菌、真菌等に抗菌活性を発揮するビス
第四アンモニウム塩化合物は古くから知られており、現
在も広く一般に用いられている。しかしながらこのよう
な化合物は通常、抗菌活性に優れていると同時に生分解
生成物の残留毒性も高いため、実際の使用に際しては安
全性を考慮し、その応用範囲には制限がある。
2. Description of the Related Art Bis-quaternary ammonium salt compounds exhibiting antibacterial activity against bacteria, fungi and the like have been known for a long time and are still widely used. However, since such compounds usually have excellent antibacterial activity and high residual toxicity of biodegradation products, their application range is limited in consideration of safety in actual use.

【0003】そのため、従来より抗菌活性に極めて優
れ、かつ、生分解後は残留毒性が低く、地球環境に優し
いビス第四アンモニウム塩化合物の開発が強く望まれて
いる。
[0003] Therefore, there has been a strong demand for the development of bis-quaternary ammonium salt compounds which are extremely excellent in antibacterial activity, have low residual toxicity after biodegradation, and are environmentally friendly.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、既知
の第四アンモニウム塩化合物に比べて、極めて優れた殺
菌効果と広い抗菌スペクトルを示し、かつ、安全性の高
い新規なビス第四アンモニウム塩化合物及びその製造法
を提供することにある。
DISCLOSURE OF THE INVENTION An object of the present invention is to provide a novel bisquaternary ammonium compound which exhibits a very excellent bactericidal effect and a broad antibacterial spectrum as compared with known quaternary ammonium salt compounds, and is highly safe. An object of the present invention is to provide a salt compound and a method for producing the same.

【0005】[0005]

【課題を解決するための手段】本発明は、一般式(1)According to the present invention, there is provided a compound represented by the general formula (1):

【0006】[0006]

【化3】 Embedded image

【0007】[式中、Zはピリジン環を示し、R1及び
2は同一または異なり、各々水素原子又は炭素数1〜
6のアルキル基を示し、R3は炭素数3〜18のアルキ
レン基又はアルケニレン基を示し、R4はZの環窒素原
子に結合した炭素数6〜18のアルキル基を示し、Xは
アニオンを示す]で表される抗菌活性を有するビス第四
アンモニウム塩化合物を提供するものである。
[In the formula, Z represents a pyridine ring, R 1 and R 2 are the same or different and each represents a hydrogen atom or a carbon number of 1 to 1;
6 represents an alkyl group, R 3 represents a C 3-18 alkylene group or an alkenylene group, R 4 represents a C 6-18 alkyl group bonded to a ring nitrogen atom of Z, and X represents an anion. The present invention provides a bis-quaternary ammonium salt compound having an antibacterial activity represented by [1].

【0008】上記一般式(1)において、R3のアルキ
レン基及びアルケニレン基としては炭素数3〜18のも
のが用いられるが、殺菌力の観点からは炭素数4〜12
のものが好ましい。また、R4のアルキル基としては炭
素数6〜18のものが用いられるが、殺菌力の観点から
炭素数8〜14のものが好適である。さらに、Xによっ
て示されるアニオンは、特に限定されるものではなく、
例えば、I-、Br-、Cl-、NO3 -等の無機アニオ
ン;CH3COO-等の有機酸アニオンなどが挙げられ
る。
In the above general formula (1), as the alkylene group and alkenylene group of R 3 , those having 3 to 18 carbon atoms are used. From the viewpoint of bactericidal activity, 4 to 12 carbon atoms are used.
Are preferred. As the alkyl group for R 4 , those having 6 to 18 carbon atoms are used, and those having 8 to 14 carbon atoms are preferable from the viewpoint of bactericidal activity. Further, the anion represented by X is not particularly limited,
Examples thereof include inorganic anions such as I , Br , Cl , and NO 3 ; organic acid anions such as CH 3 COO .

【0009】本発明の化合物は、一般式(2)The compound of the present invention has the general formula (2):

【0010】[0010]

【化4】 Embedded image

【0011】[式中、Z、R1、R2及びR3は前記の意
味を有する]で表されるアルキレンビスカルバモイルピ
リジン化合物を一般式(3) R4X (3) [式中、R4及びXは前記の意味を有する]で表される
化合物と反応させることにより製造することができる。
An alkylenebiscarbamoylpyridine compound represented by the formula: wherein Z, R 1 , R 2 and R 3 have the above-mentioned meanings is represented by the general formula (3) R 4 X (3) 4 and X have the above meanings] and can be produced.

【0012】上記反応は、通常、有機溶媒中、例えば、
N,N−ジメチルホルムアミド、N−メチルホルムアミ
ド、ニトロメタン、ニトロエタン等の中で、約50〜約
100℃の温度で行なうことができる。反応時間は18
〜48時間程度とすることができる。
The above reaction is usually carried out in an organic solvent, for example,
It can be carried out in N, N-dimethylformamide, N-methylformamide, nitromethane, nitroethane or the like at a temperature of about 50 to about 100 ° C. Reaction time is 18
It can be about 48 hours.

【0013】或いは上記反応は、溶媒の存在下に、オー
トクレーブ中で加圧下、好ましくは約10〜約100M
Paにおいて約50〜100℃の温度で行なうこともで
きる。このときの反応時間は10〜120時間程度とす
ることができる。
Alternatively, the above reaction is carried out under pressure in an autoclave in the presence of a solvent, preferably about 10 to about 100M.
It can also be performed at a temperature of about 50 to 100 ° C. in Pa. The reaction time at this time can be about 10 to 120 hours.

【0014】式(2)の化合物と式(3)の化合物との
反応割合は厳密に制限されるものではないが、通常、式
(2)の化合物1モルに対して式(3)の化合物を2〜
6モル、特に2.1〜3モルの割合で使用するのが好適
である。
The reaction ratio between the compound of the formula (2) and the compound of the formula (3) is not strictly limited, but is usually 1 mole of the compound of the formula (2) and the compound of the formula (3). To 2
It is preferably used in a proportion of 6 mol, especially 2.1 to 3 mol.

【0015】上記反応により生成する式(1)の化合物
は、それ自体既知の精製方法、例えば、再結晶等により
精製することができる。
The compound of formula (1) produced by the above reaction can be purified by a purification method known per se, for example, recrystallization and the like.

【0016】上記反応において出発原料として使用され
る式(2)の化合物は、一部は既知のものも含まれてい
るが(特開昭55−81861号公報、特開平3−81
222号公報参照)、例えば、下記式(4) Z−COCl・HCl (4) [式中、Zは前記の意味を有する]で表される化合物を
下記式(5)
The compound of the formula (2) used as a starting material in the above reaction includes some known compounds (JP-A-55-81861 and JP-A-3-81).
222), for example, a compound represented by the following formula (4) Z-COCl.HCl (4) [wherein Z has the above meaning] is represented by the following formula (5).

【0017】[0017]

【化5】 Embedded image

【0018】[式中、R1、R2及びR3は前記の意味を
有する]で表されるα,ω−ジアミノアルカンと反応さ
せることによって合成することができる。
It can be synthesized by reacting with an α, ω-diaminoalkane represented by the formula [wherein R 1 , R 2 and R 3 have the above-mentioned meanings].

【0019】式(4)の化合物と式(5)の化合物との
反応は、通常、適当な有機溶媒中で室温ないし約100
℃の温度において実施することができる。式(4)の化
合物に対する式(5)の化合物の使用割合は特に制限さ
れないが、通常、式(5)の化合物1モルに対して式
(4)の化合物を2〜4モル、特に2.1〜2.5モル
の割合で用いるのが好適である。
The reaction of the compound of formula (4) with the compound of formula (5) is usually from room temperature to about 100 in a suitable organic solvent.
It can be carried out at a temperature of ° C. The ratio of the compound of the formula (5) to the compound of the formula (4) is not particularly limited, but usually 2 to 4 mol of the compound of the formula (4), particularly 2. It is preferably used in a ratio of 1 to 2.5 mol.

【0020】生成する式(2)の化合物は、必要に応じ
て、再結晶等の手段により精製することができる。
The resulting compound of formula (2) can be purified by means such as recrystallization, if necessary.

【0021】上記の反応において用いられる式(4)の
化合物としては、例えば、イソニコチン酸クロリド、ニ
コチン酸クロリド、ピコリン酸クロリド等が挙げられ、
また、式(5)のα,ω−ジアミノアルカン類として
は、例えば、トリメチレンジアミン、テトラメチレンジ
アミン、ぺンタメチレンジアミン、ヘキサメチレンジア
ミン、オクタメチレンジアミン、デカメチレンジアミ
ン、ドデカメチレンジアミンなどを使用することができ
る。
Examples of the compound of the formula (4) used in the above reaction include isonicotinic acid chloride, nicotinic acid chloride, picolinic acid chloride, and the like.
Further, as the α, ω-diaminoalkanes of the formula (5), for example, trimethylenediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, octamethylenediamine, decamethylenediamine, dodecamethylenediamine, etc. are used. can do.

【0022】一方、前記式(2)の化合物との反応に用
いられる式(3)の化合物としては、例えば沃化ヘキサ
ン、沃化オクタン、沃化デカン、沃化ドデカン、沃化テ
トラデカン、沃化ヘキサデカン、沃化オクタデカン、臭
化ヘキサン、臭化オクタン、臭化デカン、臭化ドデカ
ン、臭化テトラデカン、臭化ヘキサデカン、臭化オクタ
デカン、塩化ヘキサン、塩化オクタン、塩化デカン、塩
化ドデカン、塩化テトラデカン、塩化ヘキサデカン、塩
化オクタデカンなどが挙げられる。
On the other hand, examples of the compound of formula (3) used in the reaction with the compound of formula (2) include hexane iodide, octane iodide, decane iodide, dodecane iodide, tetradecane iodide, and iodide. Hexadecane, octadecane iodide, hexane bromide, octane bromide, decane bromide, dodecane bromide, tetradecane bromide, hexadecane bromide, octadecane bromide, hexane chloride, octane chloride, decane chloride, dodecane chloride, tetradecane chloride, chloride Examples include hexadecane and octadecane chloride.

【0023】以上述べた如くして製造される式(1)の
化合物におけるアニオン(X)は、必要に応じて、例え
ば、式(1)の化合物を可溶性溶媒に溶解した後、希望
するアニオンを含有する塩を加え、反応後、濃縮、乾
燥、精製することにより、所望のアニオンと交換するこ
とができる。
The anion (X) in the compound of the formula (1) produced as described above is, for example, if necessary, after dissolving the compound of the formula (1) in a soluble solvent, the desired anion is added. A desired anion can be exchanged by adding a salt contained therein, concentrating, drying and purifying after the reaction.

【0024】本発明の式(1)の化合物は、後記の試験
例1及び2に示すとおり、種々の細菌、真菌に対して広
い殺菌スペクトルを有しており、しかも、従来の市販の
第四アンモニウム塩等に比べて、1/10〜1/100
の最小殺菌濃度という優れた殺菌活性を示す。
The compound of the formula (1) of the present invention has a broad bactericidal spectrum against various bacteria and fungi as shown in Test Examples 1 and 2 to be described later, and the conventional commercially available fourth compound is used. 1/10 to 1/100 compared to ammonium salts
It shows an excellent bactericidal activity of the minimum bactericidal concentration of.

【0025】従って、本発明の式(1)の化合物は、従
来の市販の同種の殺菌剤よりもはるかに少ない使用濃度
で従来の殺菌剤と同等の殺菌効果を期待することがで
き、従って、経済的であり且つ人体に対する安全性もそ
れだけ向上する。さらに、本発明の式(1)の化合物の
生分解生成物は、殺菌活性が1000分の1に低下する
ため、本発明の化合物は環境に対して優しい薬剤という
ことができる。
Therefore, the compound of the formula (1) of the present invention can be expected to have the same bactericidal effect as that of the conventional bactericide at a use concentration much lower than that of the conventional commercially available bactericide of the same kind. It is economical and the safety to the human body is improved accordingly. Furthermore, since the biodegradation product of the compound of formula (1) of the present invention has a bactericidal activity reduced to 1/1000, it can be said that the compound of the present invention is an environmentally friendly drug.

【0026】[0026]

【実施例】以下、実施例及び試験例により本発明をさら
に具体的に説明する。
The present invention will be described more specifically with reference to the following examples and test examples.

【0027】実施例1 中間体4BP-6の合成 イソニコチン酸123g(1.0mol)に過剰の塩化チオニ
ルを滴下し、完全に室温で溶解するまで撹拌する。一夜
放置後、過剰の塩化チオニルを回収し、さらに乾燥トル
エンを投入し、反応系からトルエンと共に未回収塩化チ
オニルをできるだけ減圧留去する。得られた結晶性残留
物をピリジンに懸濁させ、さらにトリエチルアミンを加
えて、フリーベースとし、ヘキサメチレンジアミン(0.
5mol)のピリジン溶液を滴下する。さらに室温で24時
間撹拌した。反応混合物に、20%K2CO3水溶液を加
え、中和、濃縮後、析出した粗晶を濾取する。粗晶は、
イソプロピルアルコール/水で再結晶、減圧乾燥によ
り、微黄褐色のN,N'-ヘキサメチレンビス(イソニコ
チン酸アミド)(以下、4BP-6と略記する)が得ら
れた。
Example 1 Synthesis of Intermediate 4BP-6 To 123 g (1.0 mol) of isonicotinic acid, excess thionyl chloride was added dropwise, and the mixture was stirred at room temperature until completely dissolved. After being left overnight, excess thionyl chloride is recovered, dry toluene is further added, and unrecovered thionyl chloride is distilled off from the reaction system together with toluene under reduced pressure as much as possible. The crystalline residue obtained was suspended in pyridine and further triethylamine was added to make it a free base.
5 mol) of pyridine solution is added dropwise. Furthermore, it stirred at room temperature for 24 hours. A 20% K 2 CO 3 aqueous solution is added to the reaction mixture, the mixture is neutralized and concentrated, and the precipitated crude crystals are collected by filtration. The crude crystals are
By recrystallization from isopropyl alcohol / water and drying under reduced pressure, a slightly yellowish brown N, N′-hexamethylenebis (isonicotinamide) (hereinafter abbreviated as 4BP-6) was obtained.

【0028】実施例2 最終化合物4BP-6,12の
合成 2.00g(6.13mmol)の4BP-6をN,N−ジメチ
ルホルムアミド40mlに溶解し、臭化ドデカン3.07
g(12.32mmol)を投入し、2日間還流した。冷後、
減圧で溶媒を留去、得られた結晶をエチルアルコールで
繰り返し再結晶、減圧乾燥し、融点84〜85℃の微黄
色粉末のN,N'−ヘキサメチレンビス(4-カルバモイ
ル−1−ドデシルピリジニウムブロマイド)(以下、4
BP-6,12と略記する)2.2gを得た。
Example 2 Synthesis of final compound 4BP-6,12 2.00 g (6.13 mmol) of 4BP-6 was dissolved in 40 ml of N, N-dimethylformamide and dodecane bromide 3.07.
g (12.32 mmol) was added, and the mixture was refluxed for 2 days. After cooling,
The solvent was distilled off under reduced pressure, and the obtained crystals were repeatedly recrystallized from ethyl alcohol and dried under reduced pressure to obtain N, N′-hexamethylenebis (4-carbamoyl-1-dodecylpyridinium) as a slightly yellow powder having a melting point of 84 to 85 ° C. Bromide) (4 below)
(Abbreviated as BP-6,12) 2.2 g was obtained.

【0029】1H−NMR(CDCl3):4BP-6,1
2(δppm) 0.85(6H,t,J=6.5Hz),1.29(36H,
s),1.37(4H,br s),1.58(4H,
m),1.92(4H,m),3.33(4H,m),4.
65(4H,t,J=7.3Hz),8.45(4H,d,J
=6.8Hz),9.27(6H,d,J=6.8Hz) 元素分析:分子式C4272Br242として C H N 理論値(%) 61.16 8.80 6.79 実測値(%) 61.10 8.93 6.68 ハロゲン分析(酸素フラスコ燃焼法) Br 理論値(%) 19.38 実測値(%) 19.56 実施例3 最終化合物4BP-6,14の合成 実施例2と同様にして、4BP-6を臭化テトラデカン
によりビス第4級塩化し、以下同様に精製し、融点11
3〜115℃の微黄色粉末のN,N'-ヘキサメチレンビ
ス(4−カルバモイル―1−テトラデシルピリジニウム
ブロマイド)(以下、4BP-6,14と略記する)を得
た。収率78.2%。
1 H-NMR (CDCl 3 ): 4BP-6,1
2 (δppm) 0.85 (6H, t, J = 6.5Hz), 1.29 (36H,
s), 1.37 (4H, br s), 1.58 (4H,
m), 1.92 (4H, m), 3.33 (4H, m), 4.
65 (4H, t, J = 7.3Hz), 8.45 (4H, d, J
= 6.8 Hz), 9.27 (6H, d, J = 6.8Hz) Elemental analysis: molecular formula C 42 H 72 Br 2 N 4 O 2 CHN theoretical value (%) 61.16 8.80 6 .79 measured value (%) 61.10 8.93 6.68 halogen analysis (oxygen flask combustion method) Br theoretical value (%) 19.38 measured value (%) 19.56 Example 3 final compound 4BP-6, Synthesis of 14 In the same manner as in Example 2, 4BP-6 was subjected to bis-quaternary chlorination with tetradecane bromide, and then purified in the same manner to give a melting point of 11
A slightly yellow powder of N, N′-hexamethylenebis (4-carbamoyl-1-tetradecylpyridinium bromide) at 3 to 115 ° C. (hereinafter, abbreviated as 4BP-6,14) was obtained. Yield 78.2%.

【0030】1H−NMR(CDCl3):4BP-6,1
4(δppm) 0.85(6H,t,J=6.5Hz),1.23(44H,
s),1.37(4H,br s),1.58(4H,
m),1.92(4H,m),3.34(4H,m),4.
65(4H,t,J=7.3Hz),8.45(4H,d,J
=6.7Hz),9.27(6H,d,J=6.7Hz) 元素分析:分子式C4680Br242として C H N 理論値(%) 62.72 9.15 6.36 実測値(%) 62.61 8.93 6.47 ハロゲン分析(酸素フラスコ燃焼法) Br 理論値(%) 18.14 実測値(%) 17.98 実施例4 最終化合物4BP-6,16の合成 実施例2と同様にして、4BP-6を臭化ヘキサデカン
によりビス第4級塩化し、以下同様に精製し、融点11
2〜113℃の微黄色粉末のN,N'−ヘキサメチレンビ
ス(4−カルバモイル―1−ヘキサデシルピリジニウム
ブロマイド)(以下、4BP-6,16と略記する)を得
た。収率86.5%。
1 H-NMR (CDCl 3 ): 4BP-6,1
4 (δppm) 0.85 (6H, t, J = 6.5Hz), 1.23 (44H,
s), 1.37 (4H, br s), 1.58 (4H,
m), 1.92 (4H, m), 3.34 (4H, m), 4.
65 (4H, t, J = 7.3Hz), 8.45 (4H, d, J
= 6.7 Hz), 9.27 (6H, d, J = 6.7 Hz) Elemental analysis: molecular formula C 46 H 80 Br 2 N 4 O 2 CHN theoretical value (%) 62.72 9.15 6 .36 measured value (%) 62.61 8.93 6.47 halogen analysis (oxygen flask combustion method) Br theoretical value (%) 18.14 measured value (%) 17.98 Example 4 final compound 4BP-6, Synthesis of 16 In the same manner as in Example 2, 4BP-6 was subjected to bis-quaternary chlorination with hexadecane bromide and then purified in the same manner to give a melting point of 11
A slightly yellow powder of N, N′-hexamethylenebis (4-carbamoyl-1-hexadecylpyridinium bromide) at 2 to 113 ° C. (hereinafter abbreviated as 4BP-6,16) was obtained. Yield 86.5%.

【0031】1H−NMR(CDCl3):4BP-6,1
6(δppm) 0.85(6H,t,J=6.4Hz),1.23(52H,
s),1.37(4H,br s),1.55(4H,
m),1.92(4H,m),3.28(4H,m),4.
65(4H,t,J=7.2Hz),8.45(4H,d,J
=6.7Hz),9.27(6H,d,J=6.7Hz) 元素分析:分子式C5088Br242として C H N 理論値(%) 64.09 9.47 5.98 実測値(%) 63.91 9.38 6.07 ハロゲン分析(酸素フラスコ燃焼法) Br 理論値(%) 17.05 実測値(%) 16.96 実施例5 最終化合物4BP-6,10の合成 実施例2と同様にして、4BP-6を臭化デカンにより
ビス第4級塩化し、以下同様に精製し、融点128〜1
30℃の微黄色粉末のN,N'-ヘキサメチレンビス(4-
カルバモイル―1-デシルピリジニウムブロマイド)
(以下、4BP-6,10と略記する)を得た。収率8
5.7%。
1 H-NMR (CDCl 3 ): 4BP-6,1
6 (δppm) 0.85 (6H, t, J = 6.4Hz), 1.23 (52H,
s), 1.37 (4H, br s), 1.55 (4H,
m), 1.92 (4H, m), 3.28 (4H, m), 4.
65 (4H, t, J = 7.2Hz), 8.45 (4H, d, J
= 6.7 Hz), 9.27 (6H, d, J = 6.7 Hz) Elemental analysis: molecular formula C 50 H 88 Br 2 N 4 O 2 CHN theoretical value (%) 64.09 9.47 5 .98 measured value (%) 63.91 9.38 6.07 halogen analysis (oxygen flask combustion method) Br theoretical value (%) 17.05 measured value (%) 16.96 Example 5 final compound 4BP-6, Synthesis of 10 In the same manner as in Example 2, 4BP-6 was subjected to bis-quaternary chlorination with decane bromide, and then purified in the same manner to give a melting point of 128-1.
N, N'-hexamethylenebis (4-
Carbamoyl-1-decylpyridinium bromide)
(Hereinafter, abbreviated as 4BP-6,10) was obtained. Yield 8
5.7%.

【0032】1H−NMR(CDCl3):4BP-6,1
0(δppm) 0.85(6H,t,J=6.5Hz),1.28(28H,
s),1.37(4H,br s),1.58(4H,
m),1.92(4H,m),3.31(4H,m),4.
65(4H,t,J=7.3Hz),8.45(4H,d,J
=6.8Hz),9.27(6H,d,J=6.8Hz) 元素分析:分子式C3864Br242として C H N 理論値(%) 59.37 8.39 7.29 実測値(%) 59.21 8.23 6.37 ハロゲン分析(酸素フラスコ燃焼法) Br 理論値(%) 20.79 実測値(%) 20.82 実施例6 最終化合物4BP-6,8の合成 実施例2と同様にして、4BP-6を臭化オクタンによ
りビス第4級塩化し、以下同様に精製し、融点90〜9
1.5℃の微黄色粉末のN,N'-ヘキサメチレンビス(4
-カルバモイル―1-オクチルピリジニウムブロマイド)
(以下、4BP-6,8と略記する)を得た。収率81.
7%。
1 H-NMR (CDCl 3 ): 4BP-6,1
0 (δppm) 0.85 (6H, t, J = 6.5Hz), 1.28 (28H,
s), 1.37 (4H, br s), 1.58 (4H,
m), 1.92 (4H, m), 3.31 (4H, m), 4.
65 (4H, t, J = 7.3Hz), 8.45 (4H, d, J
= 6.8 Hz), 9.27 (6H, d, J = 6.8 Hz) Elemental analysis: molecular formula C 38 H 64 Br 2 N 4 O 2 CHN theoretical value (%) 59.37 8.39 7 .29 measured value (%) 59.21 8.23 6.37 halogen analysis (oxygen flask combustion method) Br theoretical value (%) 20.79 measured value (%) 20.82 Example 6 final compound 4BP-6, Synthesis of 8 In the same manner as in Example 4, 4BP-6 was subjected to bis-quaternary chlorination with octane bromide, and then purified in the same manner to give a melting point of 90 to 9
N, N'-hexamethylenebis (4
-Carbamoyl-1-octylpyridinium bromide)
(Hereinafter, abbreviated as 4BP-6,8) was obtained. Yield 81.
7%.

【0033】1H−NMR(CDCl3):4BP-6,8
(δppm) 0.85(6H,t,J=6.5Hz),1.27(20H,
s),1.37(4H,br s),1.58(4H,
m),1.92(4H,m),3.34(4H,m),4.
65(4H,t,J=7.2Hz),8.45(4H,d,J
=6.8Hz),9.27(6H,d,J=6.8Hz) 元素分析:分子式C3456Br242として C H N 理論値(%) 57.30 7.92 7.86 実測値(%) 57.16 8.02 8.04 ハロゲン分析(酸素フラスコ燃焼法) Br 理論値(%) 22.42 実測値(%) 22.28 なお、上記実施例において得られた本発明の化合物をま
とめて示せば、下記表1のとおりである。
1 H-NMR (CDCl 3 ): 4BP-6,8
(Δppm) 0.85 (6H, t, J = 6.5Hz), 1.27 (20H,
s), 1.37 (4H, br s), 1.58 (4H,
m), 1.92 (4H, m), 3.34 (4H, m), 4.
65 (4H, t, J = 7.2Hz), 8.45 (4H, d, J
= 6.8 Hz), 9.27 (6H, d, J = 6.8 Hz) Elemental analysis: molecular formula C 34 H 56 Br 2 N 4 O 2 CHN theoretical value (%) 57.30 7.927 7 .86 measured value (%) 57.16 8.02 8.04 halogen analysis (oxygen flask combustion method) Br theoretical value (%) 22.42 measured value (%) 22.28 In addition, it was obtained in the above-mentioned Example. The compounds of the present invention are summarized in Table 1 below.

【0034】[0034]

【表1】 [Table 1]

【0035】試験例1 真菌に対する最小発育阻止濃度
(MIC)の測定 エタノールに表1に記載の化合物をそれぞれ500pp
m(μg/ml)となるように溶解した。この薬剤溶液
を無菌蒸留水で2倍の段階希釈を10回繰り返し、希釈
系列を調製した。
Test Example 1 Minimum inhibitory concentration against fungi
(MIC) measurement 500 pp of each of the compounds listed in Table 1 was added to ethanol.
It melt | dissolved so that it might become m (microgram / ml). This drug solution was serially diluted twice with sterile distilled water ten times to prepare a dilution series.

【0036】一方、PDA培地で10〜14日間培養し
た供試菌を106cell/mlとなるように湿潤剤添加
殺菌水で胞子液を調製した。希釈薬剤溶液1mlと胞子
液1mlを混合し、インキュべーター中で27℃/一週
間培養後、増殖の有無を濁度で判定し、濁りを生じてい
ないときの最小薬剤濃度をMICとした。結果を下記表
2に示す。
On the other hand, a spore solution was prepared with sterilized water containing a wetting agent so that the test bacteria cultivated in a PDA medium for 10 to 14 days would have a concentration of 10 6 cells / ml. 1 ml of the diluted drug solution and 1 ml of the spore solution were mixed, and after culturing in an incubator at 27 ° C. for 1 week, the presence or absence of proliferation was determined by turbidity, and the minimum drug concentration when no turbidity was generated was defined as MIC. The results are shown in Table 2 below.

【0037】[0037]

【表2】 [Table 2]

【0038】試験例2 細菌に対する最小発育阻止濃度
(MIC)の測定 ニュートリエントブロス(NB培地)に薬剤(4BP―
6,12)を500ppm(μg/ml)となるように溶解し
た。この薬剤溶液をフレシュNB培地で2倍の段階希釈
を10回繰り返し、希釈系列を調製した。
Test Example 2 Minimum inhibitory concentration against bacteria
(MIC) Measurement Drug (4BP-) was added to nutrient broth (NB medium).
6, 12) was dissolved to 500 ppm (μg / ml). This drug solution was diluted with Fresh NB medium and serially diluted 2-fold 10 times to prepare a dilution series.

【0039】一方、NB培地で24時間培養した供試菌
を106cell/mlとなるようにNB培地で接種菌液
を調製した。希釈薬剤溶液1mlと接種菌液1mlを混
合し、インキュベーター中で48時間培養後、増殖の有
無を濁度で判定し、濁りが生じていない最小薬剤濃度を
MICとした。結果を下記表3に示す。
On the other hand, an inoculum solution was prepared in the NB medium so that the test strains cultured in the NB medium for 24 hours became 10 6 cells / ml. 1 ml of the diluted drug solution and 1 ml of the inoculum were mixed and cultured for 48 hours in an incubator, and then the presence or absence of proliferation was judged by turbidity, and the minimum drug concentration without turbidity was defined as MIC. The results are shown in Table 3 below.

【0040】[0040]

【表3】 [Table 3]

【0041】[0041]

【発明の効果】本発明のビス第四アンモニウム塩化合物
は、既知の第四アンモニウム塩化合物に比べて、極めて
優れた殺菌効果と広い抗菌スペクトルを示し、かつ、安
全性も高く、殺菌剤として有用である。
INDUSTRIAL APPLICABILITY The bis-quaternary ammonium salt compound of the present invention exhibits an extremely excellent bactericidal effect and a broad antibacterial spectrum as compared with known quaternary ammonium salt compounds, and is highly safe and useful as a bactericide. Is.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 難波 哲人 香川県高松市香西本町1番地 イヌイ株式 会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Tetsuto Namba 1 Kosaihonmachi, Takamatsu City, Kagawa Inui Corporation

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 一般式(1) 【化1】 [式中、Zはピリジン環を示し、R1及びR2は同一また
は異なり、各々水素原子又は炭素数1〜6のアルキル基
を示し、R3は炭素数3〜18のアルキレン基又はアル
ケニレン基を示し、R4はZの環窒素原子に結合した炭
素数6〜18のアルキル基を示し、Xはアニオンを示
す]で表される抗菌活性を有するビス第四アンモニウム
塩化合物。
1. A compound of the general formula (1) [In the formula, Z represents a pyridine ring, R 1 and R 2 are the same or different and each represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R 3 is an alkylene group having 3 to 18 carbon atoms or an alkenylene group. And R 4 represents an alkyl group having 6 to 18 carbon atoms bonded to the ring nitrogen atom of Z, and X represents an anion].
【請求項2】 一般式(2) 【化2】 [式中、Zはピリジン環を示し、R1及びR2は同一また
は異なり、各々水素原子又は炭素数1〜6のアルキル基
を示し、R3は炭素数3〜18のアルキレン基又はアル
ケニレン基を示す]で表されるアルキレンビスカルバモ
イルピリジン化合物を一般式(3) R4X (3) [式中、R4は炭素数6〜18のアルキル基を示し、X
はアニオンを示す]で表される化合物と反応させること
を特徴とする請求項1に記載の一般式(I)で表される
ビス第四アンモニウム塩化合物の製造法。
2. A compound of the general formula (2) [In the formula, Z represents a pyridine ring, R 1 and R 2 are the same or different and each represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R 3 is an alkylene group having 3 to 18 carbon atoms or an alkenylene group. Is represented by the general formula (3) R 4 X (3) [In the formula, R 4 represents an alkyl group having 6 to 18 carbon atoms, and X
Represents an anion]. The method for producing a bis-quaternary ammonium salt compound represented by the general formula (I) according to claim 1, wherein
JP29500195A 1995-10-19 1995-10-19 Bis quaternary ammonium salt compound having antimicrobial activity and its production Pending JPH09110692A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29500195A JPH09110692A (en) 1995-10-19 1995-10-19 Bis quaternary ammonium salt compound having antimicrobial activity and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29500195A JPH09110692A (en) 1995-10-19 1995-10-19 Bis quaternary ammonium salt compound having antimicrobial activity and its production

Publications (1)

Publication Number Publication Date
JPH09110692A true JPH09110692A (en) 1997-04-28

Family

ID=17815060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29500195A Pending JPH09110692A (en) 1995-10-19 1995-10-19 Bis quaternary ammonium salt compound having antimicrobial activity and its production

Country Status (1)

Country Link
JP (1) JPH09110692A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998851A1 (en) * 1998-11-04 2000-05-10 Inui Corporation Antibacterial and antifungal resin composition
EP1092763A2 (en) * 1999-10-12 2001-04-18 Inui Corporation Antimicrobial detergent composition
JP2004067540A (en) * 2002-08-02 2004-03-04 Japan Enviro Chemicals Ltd Alga-controlling agent and alga-controlling method
WO2006064875A1 (en) * 2004-12-16 2006-06-22 Nippon Soda Co., Ltd. Novel bis(quaternary ammonium salt) compound with bactericidal activity

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998851A1 (en) * 1998-11-04 2000-05-10 Inui Corporation Antibacterial and antifungal resin composition
US6251381B1 (en) 1998-11-04 2001-06-26 Inui Corporation Antibacterial and antifungal resin composition
EP1092763A2 (en) * 1999-10-12 2001-04-18 Inui Corporation Antimicrobial detergent composition
US6436890B1 (en) * 1999-10-12 2002-08-20 Inui Corporation Antimicrobial detergent composition
EP1092763A3 (en) * 1999-10-12 2003-02-12 Inui Corporation Antimicrobial detergent composition
JP2004067540A (en) * 2002-08-02 2004-03-04 Japan Enviro Chemicals Ltd Alga-controlling agent and alga-controlling method
WO2006064875A1 (en) * 2004-12-16 2006-06-22 Nippon Soda Co., Ltd. Novel bis(quaternary ammonium salt) compound with bactericidal activity
JPWO2006064875A1 (en) * 2004-12-16 2008-06-12 日本曹達株式会社 Novel bis-quaternary ammonium salt compound having bactericidal activity
JP4588034B2 (en) * 2004-12-16 2010-11-24 日本曹達株式会社 Novel bis-quaternary ammonium salt compound having bactericidal activity

Similar Documents

Publication Publication Date Title
US5721365A (en) N-substituted piperazine NONOates
JPH11505535A (en) Preparation of pyridine-2,6-diamine
JPS58154582A (en) Novel camptothecin derivative and its preparation
JPH1095773A (en) Bisquaternary ammonium salt compound having antimicrobial activity and its production
EP0118913B1 (en) Porphyrin derivatives
JPH09110692A (en) Bis quaternary ammonium salt compound having antimicrobial activity and its production
JPH10287566A (en) Bis quaternary ammonium salt compound having antimicrobial activity and its production
JP3457028B2 (en) Quaternary ammonium salt compound having antibacterial activity and method for producing the same
JPH07116116B2 (en) Process for producing 3-aminoacrylic acid ester
JP2004345953A (en) New quaternary ammonium salt compound having anti-bacterial activity and method for producing the same
JP4152353B2 (en) Bactericidal pyridine compound
US3027371A (en) Molybdenum-containing derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
CN110372533B (en) Cationic linear chloramine antibacterial agent and synthetic method thereof
SU602114A3 (en) Method of producing n'-(aminoacylaminophenyl)-acetamidines
JPH0625109B2 (en) Quaternary ammonium salt compound
KR930006948B1 (en) Method for producing a derivative of amide
US4243596A (en) (5-Nitro-2-furyl)vinylene-2-trimethylammonium bromide and method of preparing same
US2422619A (en) Vitamin b6 intermediates
US4071547A (en) 3-Bromo-2,2-bis(bromomethyl)propyl bromomethanesulfonate
JPH07316131A (en) Production of pyrrole derivative
US3821295A (en) Process for the production of alpha-amino-acid hydrohalides
Choi et al. The crystal structure of one-dimensional carboxylate-bridged zinc (II) complex with bis (2-pyridylmethyl) amino-4-butyric acid
EP0022174A1 (en) Process for preparing pyrenzepine and compound so obtained
KR900001079B1 (en) A preparation process for quinolone derivatives
SU492515A1 (en) Unsaturated selenium amines, as bactericides

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060620

A02 Decision of refusal

Effective date: 20061128

Free format text: JAPANESE INTERMEDIATE CODE: A02